Immune Activation and Decreased Tryptophan in Patients with HIV-1 Infection
Data up to Jan 2025
Total Citations Per Year
Abstract
References (15)
Neopterin as a marker for activated cell-mediated immunity: Application in HIV infection
1988 • 573 citations
II. Excitotoxic models for neurodegenerative disorders
1984 • 469 citations
Neurological and neuropshychological manifestations of HIV‐1 infection: Association with AIDS‐related complex but not asymptomatic HIV‐1 infection
1989 • 206 citations
Decreased serum tryptophan in patients with HIV-1 infection correlates with increased serum neopterin and with neurologic/psychiatric symptoms.
1990 • 203 citations
Cerebrospinal fluid quinolinic acid concentrations are increased in acquired immune deficiency syndrome
1989 • 190 citations
Human macrophages degrade tryptophan upon induction by interferon-gamma
1987 • 182 citations
Induction of Tryptophan DegradationIn VitroandIn Vivo: A γ-Interferon-Stimulated Activity
1986 • 181 citations
Interferon-gamma concentrations are increased in sera from individuals infected with human immunodeficiency virus type 1.
1989 • 119 citations
Tumour Necrosis Factor-α and Lipopolysaccharide Enhance Interferon-Induced Tryptophan Degradation and Pteridine Synthesis in Human Cells
1989 • 113 citations
Neopterin concentrations in cerebrospinal fluid and serum of individuals infected with HIV-1
1989 • 110 citations
Elevated neopterin and beta2-microglobulin levels in blood and cerebrospinal fluid occur early in HIV-1 infection
1989 • 88 citations
Tryptophan Degradation in Patients Infected by Human Immunodeficiency Virus
1988 • 83 citations
Natural antibodies to IFN-gamma in man and their increase during viral infection.
1990 • 71 citations
Indole amine deficiency in blood and cerebrospinal fluid from patients with human immunodeficiency virus infection
1989 • 54 citations
Association between intrathecal anti-HIV-1 immunoglobulin G synthesis and occurrence of HIV-1 in cerebrospinal fluid
1989 • 32 citations